Clinical Trials Browser

Terminated × pembrolizumab × Endocrine × Clear all

NCT05634577 2025-06-19

A Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Mitotane in Patients With Advanced Adrenocortical Carcinoma

Phase 2 Terminated

3 enrolled 7 charts

Adrenocortical Carcinoma

NCT03190213 2021-06-22

Pembro NEC

Phase 2 Terminated

6 enrolled 13 charts

Neuroendocrine Tumors